Frequent prolonged home haemodialysis: Three old concepts, one modern solution

Nephrology Dialysis Transplantation

Volumn 18, Issue 1, 2003, Pages 16-19

  Kooistra, Menno P ^a  

^a Dianet Dialysis Centers   (Netherlands)

Author keywords

Adequacy; Daily haemodialysis; Haemodialysis; Nocturnal haemodialysis; Prolonged haemodialysis

Indexed keywords

AMINO ACID; ANTIHYPERTENSIVE AGENT; BETA 2 MICROGLOBULIN; PHOSPHATE; POLYSULFONE; UREA;

ANOREXIA; BLOOD PRESSURE REGULATION; CONCENTRATION (PARAMETERS); COST EFFECTIVENESS ANALYSIS; EDITORIAL; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; FREQUENCY ANALYSIS; HEALTH PROGRAM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOME DIALYSIS; HOSPITAL EQUIPMENT; HUMAN; LIFE EXPECTANCY; MORBIDITY; MORTALITY; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RISK ASSESSMENT; TRAINING; TREATMENT OUTCOME; UREA BLOOD LEVEL; WEIGHT GAIN;

HEMODIALYSIS, HOME; HUMANS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0037234168     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.1.16     Document Type: Editorial

References (39)

1. Kjellstrand CM, Evans RL, Petersen RJ, Shideman JR, von Hartiszch B, Buselmeier TJ. The unphysiology of dialysis: a major cause of side effects? Kidney Int 1975; 7: S30-S34
2. De Palma JR, Pecker EA, Maxwell MH. A new automatic coil dialyzer system for 'daily' dialysis. Proc Eur Dial Transplant Assoc 1969; 6: 26-34 (reprint in: Semin Dial 1999; 12: 406-409)
3. Bonomini V, Mioli V, Albertazzi A, Scolari P. Daily-dialysis programme: indications and results. Proc Eur Dial Transplant Assoc 1972; 9: 44-52 (reprint in: Nephrol Dial Transplant 1998; 13: 2774-2778)
4. Laurent G, Calemard G, Charra B. Long dialysis: a review of fifteen years experience in one centre: 1968-1983. Proc Eur Dial Transplant Assoc 1983; 20: 122-129
5. Uldall R, Ouwendyk M, Francoeur R, Wallace L, Sit W, Vas S, Pierratos A. Slow nocturnal home hemodialysis at the Wellesley Hospital. Adv Ren Replace Ther 1996; 13: 133-136
6. Lopot F, Válek A. Quantification of dialysis unphysiology. Nephrol Dial Transplant 1998; 13 [Suppl 6]: 74-78
7. Depner TA. Benefits of more frequent dialysis: lower TAC at the same KT/V. Nephrol Dial Transplant 1998; 13 [Suppl 6]: 20-24
8. Depner TA. Daily hemodialysis efficiency: an analysis of solute kinetics. Adv Ren Replace Ther 2001; 8: 227-235
9. Casino FG, Lopez T. The equivalent renal clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 1996; 11: 1574-1581
10. Gotch F. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998; 13 [Suppl 6]: 20-24
11. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M. Daily dialysis: long-term clinical metabolic results. Kidney Int 1988; 33 [Suppl 24]: S137-S140
12. Kooistra MP, Vos J, Koomans HA, Vos P. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13: 2853-2860
13. Traeger J, Sibai-Galland R, Delawari E, Arkouche W. Daily versus standard hemodialysis: one year experience. Artif Organs 1998; 22: 558-563
14. Ting G, Freitas T, Saum N, Carrie B, Kjellstrand C. Early metabolic, hematological, clinical, and life quality changes with daily hemodialysis. Perit Dial Int 1998; 18 [Suppl 1]: S78.
15. Woods JD, Port FK, Orzol S et al. Clinical and biochemical correlates of starting 'daily' dialysis. Kidney Int 1999; 55: 2467-2476
16. Buoncristiani U, Fagugli R, Kulurianu H, Ciao G. Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialyzed patients. Int J A rtif Organs 1997; 20: 502
17. Williams AW, O'Sullivan DA, McCarthy JT. Slow nocturnal and short daily hemodialysis: a comparison. Semin Dial 1999; 12: 431-439
18. David S, Bottalico D, Tagliavini D, Mandolfo S, Scanziani R, Cambi V. Behaviour of beta-2 microglobulin removal with different dialysis schedules. Nephrol Dial Transplant 1998; 13 [Suppl 6]: 49-54
19. DeSoy C, Umans JG. Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol 1993; 4: 1214-1218
20. Fagugli RM, Reboldi G, Quintaliani G et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001; 38: 371-376
21. Zilch O, Vos PF, Oey LP, Cramer MJM, Koomans HA, Blankestijn PJ. Daily dialysis reduces peripheral vascular resistance and sypathetic activity. J Am Soc Nephrol 2001; 12: 280A (abstract)
22. Buoncristiani U, Cairo G, Giombini L, Quintaliani G, Bonforte G. Dramatic improvement of clinical-metabolic parameters and quality of life with daily dialysis. Int J Artif Organs 1989; 12: 133-136
23. Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 1998; 13 [Suppl 6]: 125-131
24. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35-44
25. Katzarski KS, Charra B, Luik AJ et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14: 369-375
26. Evans RW, Manninen DL, Garrison LP, Jr et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553-559
27. Kutner NG, Brogan D, Kutner MH. End-stage renal disease treatment modality and patient's quality. of life. Longitudinal assessment. Am J Nephrol 1986; 6: 396-402
28. Bremer BA, McCauly CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: a reexamniation. Am J Kidney Dis 1989; 13: 200-209
29. Meers C, Singer MA, Toffelmire EB. Self delivery of hemodialysis care: a therapy in itself. Am J Kidney Dis 1996; 27: 844-847
30. Woods JD, Port FK, Stannard D, Blagg CR, Held PJ. Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 1996; 49: 1464-1470
31. Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999; 14: 2835-2840
32. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal haemodialysis. Kidney Int 1998; 53: 1399-1404
33. Raj DS, Ouwendyk M, Francoeur R, Pierratos A. Beta-2 microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000; 15: 58-64
34. Raj DS, Ouwendyk M, Francoeur R, Pierratos A. Plasma amino acid profile on nocturnal hemodialysis. Blood Purif 2000; 18: 97-102
35. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A. Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol 2002; 13: 265-268
36. Chan CT, Floras JS, Miller JA, Richardson RMA, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61: 2235-2239
37. Brissenden JE, Pierratos A, Ouwendyk M, Roscoe JM. Improvements in quality of life with nocturnal hemodialysis. J Am Soc Nephrol 1998; 9: 168A (abstract)
38. Hanly P, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344: 102-107
39. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001; 37: 777-789